Florbetapir

CHEMBL1908919 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

359.4 g/mol

LogP

3.5

Phase

4

Used as a PET radiotracer, this agent binds to amyloid beta plaques in the brain, enabling imaging studies that help evaluate cognitive impairment.

Moleküler Ağırlık

359,4000 g/mol

LogP

3,50

TPSA

52,60 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Alzheimer's Disease Parkinson's Disease Epilepsy Multiple Sclerosis Stroke Major Depressive Disorder

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CNc1ccc(/C=C/c2ccc(OCCOCCOCCF)nc2)cc1

InChI

InChI=1S/C20H25FN2O3/c1-22-19-7-4-17(5-8-19)2-3-18-6-9-20(23-16-18)26-15-14-25-13-12-24-11-10-21/h2-9,16,22H,10-15H2,1H3/b3-2+

Molecular Formula

C20H25FN2O3

HBD / HBA

1 / 6

Döndürülebilir Bağlar

12

Ağır Atomlar

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Used as a PET radiotracer, this agent binds to amyloid beta plaques in the brain, enabling imaging studies that help evaluate cognitive impairment.

Yes, Florbetapir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1908919. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 24822371. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Florbetapir PillFYI'da

Yapı

Hızlı Veriler

Formül: C20H25FN2O3
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.